Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population

Acta Psychiatrica Scandinavica

Volumn 124, Issue 5, 2011, Pages 372-383

  Lobo, A ^a,b,c,d   Lopez Anton, R ^c   Santabarbara J ^b,c   de la Camara C ^a,b,c,d   Ventura, T ^b,c,d,e   Quintanilla, M A ^a   Roy, J F ^b,c   Campayo, A J ^a,b,c,d   Lobo, E ^a,b,c,d   Palomo, T ^c,f   Rodriguez Jimenez, R ^c,f   Saz, P ^b,c   Marcos, G ^b,c,d,g  

^a Hosp Clin Univ   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Aged; Alzheimer disease; Dementia; Epidemiology; Incidence; Risk

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; EDUCATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTHERN EUROPE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; EDUCATIONAL STATUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 80053932176     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01754.x     Document Type: Article

References (57)

1. Jorm AF, Jolley D. The incidence of dementia A meta-analysis. Neurology 1998;51:728-733.
2. Fratiglioni L, Launer LJ, Andersen K et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11 Suppl 5):S10-S15.
3. Kukull WA, Higdon R, Bowen JD et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 2002;59:1737-1746.
4. Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM. Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement 2008;4:316-323.
5. Ott A, Breteler MM, Van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998;147:574-580.
6. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol 2007;6:1106-1114.
7. Fortin JM, Hirota LK, Bond BE, O'connor AM, Col NF. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak 2001;1:2.
8. Seshadri S, Beiser A, Kelly-Hayes M et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37:345-350.
9. Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc 2009;108:754-764.
10. Gurland BJ, Wilder DE, Lantigua R et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry 1999;14:481-493.
11. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999;66:177-183.
12. Lobo A, Saz P, Marcos G et al. The ZARADEMP Project on the incidence, prevalence and risk factors of dementia (and depression) in the elderly community: II. Methods and first results. Eur J Psychiatry 2005;19:40-54.
13. Lobo A, Saz P, Marcos G, Día JL, De-La-Cámara C. The prevalence of dementia and depression in the elderly community in a Southern European population. The Zaragoza study. Arch Gen Psychiatry 1995;52:497-506.
14. Lobo A, Saz P, Marcos G et al. [Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population]. Med Clin (Barc) 1999;112:767-774.
15. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
17. Copeland JR, Dewey ME, Wood N, Searle R, Davidson IA, Mcwilliam C. Range of mental illness amongst the elderly in the community: prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry 1987;150:815-823.
18. Saz P, Día JL, De La Camara C et al. Reliability and validity of the Spanish version of the GMS-AGECAT package for the assessment of dementia and cognitive disturbances. Int J Geriatr Psychiatry 1996;11:721-728.
19. Dewey ME, Copeland JRM, Lobo A, Saz P, Día JL. Computerised diagnosis from a standardised history schedule: a preliminary communication about the organic section of the HAS-AGECAT system. Int J Geriatr Psychiatry 1992;7:443-446.
20. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
21. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
22. Alvarez M, De Alaiz AT, Brun E, Cabañeros JJ, Calzon M, Cosio I. Capacidad funcional de pacientes mayores de 65 años, según el índice de Katz. Fiabilidad del método. Aten Primaria 1992;10:812-816.
23. Tárraga LL. Evaluación del deterioro cognitivo y funcional de la demencia. Escalas de mayor interés en la Atención Primaria. In: Boada M, Tárraga LL, eds. El médico ante la demencia y su entorno, Módulo 1. Barcelona: Bayer S.A, 1995:37-50.
24. Launer LJ, Andersen K, Dewey ME et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999;52:78-84.
25. Lobo-Escolar A, Saz P, Marcos G et al. Somatic and psychiatric comorbidity in the general elderly population: results from the ZARADEMP Project. J Psychosom Res 2008;65:347-355.
26. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974;2:207-210.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
28. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
29. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;206:2389-2430.
30. Fine JP, Gray RJ. A proportional hazard model for the sub-distribution of competing risks. J Am Stat Assoc 1999;94:496-509.
31. Scheike TH, Zhang MJ. Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal 2008;14:464-483.
32. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons Inc., 1980.
33. Bachman DL, Wolf PA, Linn RT et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43(3 Pt 1):515-519.
34. Ganguli M, Dodge HH, Chen P, Belle S, Dekosky ST. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology 2000;54:1109-1116.
35. Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sørensen P. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study. Neurology 1999;52:85-90.
36. Ruitenberg A, Ott A, Van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001;22:575-580.
37. Fratiglioni L, Viitanen M, Von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
38. Di Carlo A, Baldereschi M, Amaducci L et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 2002;50:41-48.
39. Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, König HH. Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand 2010;121:243-259.
40. Caputo M, Monastero R, Mariani E et al. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 2008;117:455-464.
41. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;16:751-761.
42. Lobo A, Launer LJ, Fratiglioni L et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11 Suppl 5):S4-S9.
43. Sekita A, Ninomiya T, Tanizaki Y et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand 2010;122:319-325.
44. Lobo-Escolar A, Roy JF, Saz P et al. Association of hypertension with depression in community-dwelling elderly persons: results from the ZARADEMP Project. Psychother Psychosom 2008;77:323-325.
45. Alzheimer's Association. 2010 Alzheimer's disease facts and figures. Alzheimers Dement 2010;6:158-194.
46. Huisman M, Kunst AE, Bopp M et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 2005;365:493-500.
47. Gandy S. Estrogen and neurodegeneration. Neurochem Res 2003;28:1003-1008.
48. Shumaker SA, Legault C, Kuller L et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.
49. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011;1379:188-198.
50. Cobb JL, Wolf PA, Au R, White R, D'agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
51. Tschanz JT, Welsh-Bohmer KA, Plassman BL, Norton MC, Wyse BW, Breitner JC. An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study. Neuropsychiatry Neuropsychol Behav Neurol 2002;15:28-38.
52. Crane PK, Gibbons LE, Jolley L et al. Differential item functioning related to education and age in the Italian version of the Mini-mental State Examination. Int Psychogeriatr 2006;18:505-515.
53. Instituto Nacional de Estadística. INEbase: Demografía y población; Cifras de población y Censos demográficos. Accessed June 15, 2010.
54. Llibre Rodriguez JJ, Ferri CP, Acosta D et al. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet 2008;372:464-474.
55. Mcdowell I, Xi G, Lindsay J, Tierney M. Mapping the connections between education and dementia. J Clin Exp Neuropsychol 2007;29:127-141.
56. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-532.
57. Mortimer JA. Is Alzheimer's disease a lifelong illness? Risk factors for pathological and clinical disease. In: Heston LL, ed. Progress in Alzheimer's disease and similar conditions. Washington DC: American Psychiatric Press, 1997:9-20.